-
XENE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Xenon Pharmaceuticals (XENE)
Company Profile
Quarter (USD) | Mar 25 | Dec 24 | Sep 24 | Jun 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 116.66 mm | 116.66 mm | 116.66 mm | 116.66 mm | 116.66 mm | 116.66 mm |
Cash burn (monthly) | 8.69 mm | (no burn) | 24.25 mm | 24.42 mm | 20.55 mm | 16.40 mm |
Cash used (since last report) | 14.35 mm | n/a | 40.06 mm | 40.34 mm | 33.95 mm | 27.10 mm |
Cash remaining | 102.31 mm | n/a | 76.60 mm | 76.32 mm | 82.71 mm | 89.56 mm |
Runway (months of cash) | 11.8 | n/a | 3.2 | 3.1 | 4.0 | 5.5 |
13F holders | Current |
---|---|
Total holders | 209 |
Opened positions | 28 |
Closed positions | 22 |
Increased positions | 65 |
Reduced positions | 69 |
13F shares | Current |
---|---|
Total value | 2.84 tn |
Total shares | 77.55 mm |
Total puts | 2.10 k |
Total calls | 104.80 k |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
FMR | 7.53 mm | $294.99 bn |
Avoro Capital Advisors | 5.67 mm | $222.13 bn |
Driehaus Capital Management | 4.52 mm | $177.21 bn |
Wellington Management | 3.78 mm | $148.08 bn |
Braidwell | 2.91 mm | $114.23 bn |
JHG Janus Henderson | 2.87 mm | $112.43 bn |
Commodore Capital | 2.74 mm | $107.41 bn |
Polar Capital | 2.70 mm | $105.75 bn |
Capital International Investors | 2.55 mm | $99.85 bn |
Capital World Investors | 2.29 mm | $89.95 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 May 25 | Gannon Steven | Common Shares | Option exercise | Acquire M | No | No | 12.57 | 5,144 | 64.66 k | 7,144 |
14 May 25 | Gannon Steven | Stock Option Common Shares | Option exercise | Dispose M | No | No | 12.57 | 5,144 | 64.66 k | 0 |
12 Mar 25 | Andrea DiFabio | Restricted Share Units Common Shares | Grant | Acquire A | No | No | 0 | 15,000 | 0.00 | 15,000 |
12 Mar 25 | Andrea DiFabio | Share Option Common Shares | Grant | Acquire A | No | No | 35.48 | 80,000 | 2.84 mm | 80,000 |
12 Mar 25 | Christopher John Kenney | Restricted Share Units Common Shares | Grant | Acquire A | No | No | 0 | 15,000 | 0.00 | 15,000 |
12 Mar 25 | Christopher John Kenney | Share Option Common Shares | Grant | Acquire A | No | No | 35.48 | 80,000 | 2.84 mm | 80,000 |
12 Mar 25 | Mortimer Ian | Restricted Share Units Common Shares | Grant | Acquire A | No | No | 0 | 50,000 | 0.00 | 50,000 |
12 Mar 25 | Mortimer Ian | Share Option Common Shares | Grant | Acquire A | No | No | 35.48 | 275,000 | 9.76 mm | 275,000 |
27 Jan 25 | Mortimer Ian | Common Shares | Sell | Dispose S | No | Yes | 41.07 | 1,149 | 47.19 k | 31,302 |
27 Jan 25 | Mortimer Ian | Common Shares | Option exercise | Acquire M | No | No | 17.76 | 1,149 | 20.41 k | 32,451 |